Shay Capital LLC Petros Pharmaceuticals, Inc. Transaction History

Shay Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.33 - $4.09 $369,390 - $1.14 Million	-277,737 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$1.82 - $3.2 $70,930 - $124,713	38,973 Added 16.32%	277,737 $555,000
Q2 2021 Aug 13, 2021	SELL	$2.87 - $4.11 $51,390 - $73,593	-17,906 Reduced 6.98%	238,764 $747,000
Q1 2021 Aug 13, 2021	BUY	$2.85 - $4.6 $600,580 - $969,357	210,730 Added 458.71%	256,670 $957,000
Q4 2020 Aug 13, 2021	BUY	$3.24 - $4.68 $148,845 - $214,999	45,940 New	45,940 $202,000

Ticker PTPI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 20,708,000
Market Cap $5.18M
Description
Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also develops and commercializes H100, a patented topical formulation candidate for th...

Get notified when there are updates to the investment portfolio of Shay Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Shay Capital LLC with notifications on news.